19 followers
Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised... - PubMed - NCBI https://t.co/sQupDPOpcP
Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised... - PubMed - NCBI https://t.co/sQupDPOpcP